echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Scientists discover new target for solid tumor CAR-T therapy

    Scientists discover new target for solid tumor CAR-T therapy

    • Last Update: 2022-05-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The key to CAR-T cell therapy is the genetic modification of a patient's T cells


    Moffitt researchers are working to identify tumor markers that will make CAR-T an effective treatment for patients with solid tumors


    The researchers then created CAR-T cells that targeted the OR2H1 protein


    These combined data suggest that OR2H1 may be an effective target for CAR-T therapy in solid tumors


    "Given that OR2H1 is expressed in a variety of histological subsets of solid tumors, including high-grade serous ovarian, lung, cholangiocarcinoma, prostate, and ovarian cancers of various other histologies, our work demonstrates that this treatment is effective in various


    Alexandra L.




    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.